Who owns Valeant Pharmaceuticals Int?

Key details on Valeant Pharmaceuticals Int (Ticker: VRX)

Who owns Valeant Pharmaceuticals Int?

Is VRX a good stock to own? Find out who bought Valeant Pharmaceuticals Int, who sold Valeant Pharmaceuticals Int (VRX) stock, and who holds a large position in Valeant Pharmaceuticals Int.

Fund Name Number of Shares Share Valuation As Of
Ruane, Cunniff & Goldfarb 34.31M $4.03B Dec. 31, 2013
FMR 26.13M $3.07B Dec. 31, 2013
ValueAct Holdings 18.92M $2.22B Dec. 31, 2013
T. Rowe Price Associates 14.78M $1.74B Dec. 31, 2013
Toronto-Dominion Bank 8.72M $1.02B Dec. 31, 2013
VIKING GLOBAL INVESTORS 8.33M $977.83M Dec. 31, 2013
Lone Pine Capital 7.76M $910.61M Dec. 31, 2013
Blue Ridge Capital Holdings 7.52M $279.13M Sept. 30, 2011
JPMORGAN CHASE & CO 7.44M $873.96M Dec. 31, 2013
Barclays 6.96M $814.86M Dec. 31, 2013
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 6.42M $754.12M Dec. 31, 2013
Brave Warrior Advisors 6.06M $335.11M Sept. 30, 2012
Blue Ridge Capital 5.45M $254.46M Dec. 31, 2011
BANK OF MONTREAL /CAN/ 4.96M $582.51M Dec. 31, 2013
Loomis, Sayles and 4.69M $550.74M Dec. 31, 2013
Janus Capital Management 4.54M $391.19M June 30, 2013
CIBC World Markets 4.44M $520.73M Dec. 31, 2013
Brave Warrior Capital 4.41M $236.94M March 31, 2012
Brahman Capital 4.36M $241.01M Sept. 30, 2012
Connor, Clark & Lunn Investment Management 4.25M $529.78M Dec. 31, 2013
Caisse de depot et placement du Quebec 4.06M $476.25M Dec. 31, 2013
Orbis Holdings 4.01M $418.70M Sept. 30, 2013
Name Goodman & Company, Investment Counsel 3.95M $230.07M Dec. 31, 2012
Royal Bank of Canada 3.92M $460.69M Dec. 31, 2013
TD Asset Management 3.78M $169.43M June 30, 2012
Iridian Asset Management 3.76M $282.43M March 31, 2013
MORGAN STANLEY 3.72M $429.61M Dec. 31, 2013
Greystone Managed Investment 3.71M $204.45M Sept. 30, 2012
GOLDMAN SACHS 3.56M $212.91M Dec. 31, 2012

Who sold Valeant Pharmaceuticals Int?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Sept. 30, 2012 4.86M $255.76M
HARRIS FINANCIAL Sept. 30, 2011 5.69M $211.13M
Nicholas Investments Partners June 30, 2011 4.40M $4.36M
Osterweis Capital Management March 31, 2011 3.62M $180.43M
Commerzbank Aktiengesellschaft Dec. 31, 2010 5.42M $153.32M